Stem Cell Blog

Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.



AdobeStock_232479875-980x551-1.jpeg

A new study conducted by researchers at the Mayo Clinic has found that stem cell treatment for patients with advanced heart failure offers an improved quality of life.

As many as 100,000 people are admitted to hospital in the UK every year due to heart attacks [1]. Heart attacks can lead to heart failure, where damage to cardiac muscles makes it harder for blood to be pumped around the body.


Adita_PA_News_Image-1080x675-1.jpg

Aditi Shankar is just eight years old, but she is a pioneer of British medicine thanks to a new way in which she has received a kidney transplant. But first, a little about the girl.

Aditi has the rarest form of dwarfism in the world, Schimke immuno-osseous dysplasia (SIOD). The condition is so rare that it affects only one in one to three million people worldwide. A genetic disorder, SIOD leads to sufferers needing hip transplants, bone marrow transplants, and kidney failure. Unfortunately, the life expectancy of those with this condition is incredibly short at 11 years of age.


shutterstock_274849448-980x653-1.jpg

We’re excited to share some promising results from a recent clinical trial that holds great promise for treating Type 1 diabetes.

This ground-breaking research was presented at the American Diabetes Association‘s 83rd Scientific Sessions on June 23, 2023. The study involved six patients who were administered varying doses of stem cell-derived beta cells. The results were nothing short of remarkable.


year_in_review_2021-1080x675-1.jpg

Stem cell banking gives your child access to a huge range of emerging stem cell therapies that may otherwise be unavailable to them.  The idea is that as they age their perfectly matched, banked stem cells are ready and waiting to repair damaged tissue, for example regenerating cartilage if they suffer from arthritis, or treat debilitating and ultimately terminal age related conditions such as Parkinson’s.


Michael-Schumacher-Covid.png

The doctor who treated seven-time World Champion driver, Michael Schumacher with stem cell therapy following his traumatic brain injury is now using the same treatment to help treat coronavirus.

Back in June, renowned clinical cardiac surgeon Professor Philippe Menasché performed pioneering stem cell treatment on the Formula 1 icon. Schumacher is said to have received transfusions of stem cells to reduce inflammation and help regenerate his nervous system after sustaining a life-changing brain injury almost 7 years ago.


Christmas-2020-Blog.png

2020 has been a difficult year. But the unprecedented challenges posed by the COVID-19 pandemic have also helped drive huge leaps forward in medical science.

We’ve taken some time to reflect and summarise some of the significant advancements that have been made in the last 12 months; both here at Cells4Life, and in the wider stem cell field.


parkinsons_stem_cells.jpg

Researchers at Kyoto University’s Centre for iPS Cell Research and Application in Japan are moving ahead with the world’s first application of induced pluripotent stem cells (iPSCs) to treat Parkinson’s disease.

The team, led by neurosurgeon Jun Takahashi, will now engage in a limited clinical trial to test the potential side effects.